Showing posts with label enforcement report. Show all posts
Showing posts with label enforcement report. Show all posts

Thursday, May 8, 2008

U.S. Food & Drug Administration (FDA) Daily Digest Bulletin

Update: 1
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Wed, 7 May 2008 07:03:09 -0500 (CDT)
Subject: Enforcement Report for May 7, 2008

Enforcement Report for May 7, 2008
Wed, 7 May 2008 06:16:00 -0500

Weekly report by the Food and Drug Administration, Department of Health and Human Services. It contains information on actions taken in connection with agency Regulatory activities.


Update: 2
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Wed, 7 May 2008 07:16:03 -0500 (CDT)
Subject: CDRH New Update

Skip NavigationFDA Logo links to FDA home pageCenter for Devices and Radiological Health, U.S. Food and Drug AdministrationHHS Logo links to Department of Health and Human Services website

FDA Home Page | CDRH Home Page | Search | A-Z Index U.S. Food and Drug AdministrationCenter for Devices and Radiological Health Questions?
horizonal rule
CDRHNEW Logo Date: May 7, 2008

The following new items were added to the CDRH web pages on May 6, 2008. Previous CDRH New Items can be found on the CDRHNew Page.

* Guidance for Industry and FDA Staff: Administrative Procedures for CLIA Categorization Text PDF
* Consumer Information on: Thoratec HeartMate II LVAS - P060040 Text

---


This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420

Thursday, March 27, 2008

Drug-eluting stents, Cantaloupe Products, CDER New, Enforcement Report


Update : 1

Subject: FDA Makes Recommendations on Medical Devices That Treat Blocked Heart Arteries

FDA Makes Recommendations on Medical Devices That Treat Blocked Heart Arteries
Wed, 26 Mar 2008 11:55:00 -0500

U.S. Food and Drug Administration Commissioner Andrew C. von Eschenbach today announced that the agency has issued draft guidelines to aid the development, testing and manufacture of coronary drug-eluting stents, devices used to treat blocked heart arteries.


Update : 2

Subject: Tropifresh, Inc. Recalls Whole Cantaloupe Products Because of Possible Health Risk (March 26)

Tropifresh, Inc. Recalls Whole Cantaloupe Products Because of Possible Health Risk (March 26)
Wed, 26 Mar 2008 15:33:00 -0500

Tropifresh, Inc. of Los Angeles, CA is recalling Agrolibano’s Produce Brand whole Cantaloupes because they appear to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems.


Update: 3

Subject: Enforcement Report for March 26, 2008

Enforcement Report for March 26, 2008
Wed, 26 Mar 2008 16:41:00 -0500

Weekly report by the Food and Drug Administration, Department of Health and Human Services. It contains information on actions taken in connection with agency Regulatory activities.


Update : 4

Subject: CDER New 3/26/2008

FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

CDERnew Logo

March 26, 2008



This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420

Thursday, March 20, 2008

U.S. Food & Drug Administration (FDA) Daily Digest Bulletin

Update: 1


Subject: CDRH New Update

Skip NavigationFDA Logo links to FDA home pageCenter for Devices and Radiological Health, U.S. Food and Drug AdministrationHHS Logo links to Department of Health and Human Services website

FDA Home Page | CDRH Home Page | Search | A-Z Index U.S. Food and Drug AdministrationCenter for Devices and Radiological Health Questions?
horizonal rule
CDRHNEW Logo Date: March 19, 2008

The following new items were added to the CDRH web pages on March 18, 2008. Previous CDRH New Items can be found on the CDRHNew Page.

* FDA Public Health Notification: Updated Data on Mortality Associated with the Medtronic AneuRx® Stent Graft System Text
* Medical Devices Dispute Resolution Panel Advisory Meeting, April 19, 2007 - Minutes Text

---


Update : 2

Subject: Enforcement Report for March 19, 2008

Enforcement Report for March 19, 2008
Wed, 19 Mar 2008 07:17:00 -0500

Weekly report by the Food and Drug Administration, Department of Health and Human Services. It contains information on actions taken in connection with agency Regulatory activities.


Update : 3

Subject: FDA Warning Letters Update

You are subscribed to FDA Warning Letters for U.S. Food & Drug Administration (FDA). This information has recently been updated, and is now available.


Update : 4

Subject: Mortality Data Associated with the AneuRx® Stent Graft System - Medical Device Safety Update

Healthcare providers should be aware of a new public health notification that re-emphasizes the need for continued surveillance of patients treated with endovascular grafts and to provide updated information on the mortality risks associated with the use of the Medtronic AneuRx® Stent Graft System.


Update : 5

Subject: FDA Data Standards Update - Additional Section Headings' LOINC Codes & Names

Greetings,

The FDA Data Standards Council's website was updated Wednesday, March 19, 2008, to include eight new LOINC codes and names for section headings.

51941-3 - PACKAGE LABEL.BACK PANEL

51947-0 - PACKAGE LABEL.BOTTOM PANEL

51948-8 - PACKAGE LABEL.FLAP PANEL

51945-4 - PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

51944-7 - PACKAGE LABEL.SIDE PANEL

51943-9 - PACKAGE LABEL.SIDE PANEL.LEFT

51942-1 - PACKAGE LABEL.SIDE PANEL.RIGHT
51946-2 - PACKAGE LABEL.TOP PANEL

Here is the hyperlink to the web page with the new LOINC codes and names: http://www.fda.gov/oc/datacouncil/loinc.html

Lonnie Smith

Project Manager

Food and Drug Administration


Update : 6

Subject: Food For Life Baking Co., Inc. Recalls Spelt Bread (March 18)

Food For Life Baking Co., Inc. Recalls Spelt Bread (March 18)
Wed, 19 Mar 2008 10:18:00 -0500

Food For Life Baking Company of Corona, California is voluntarily recalling 2,241 cases of Spelt Bread (UPC# 07347200168) because they contain spelt grain which is known to be a hybrid of wheat. People who have allergies to wheat or those with Celiac Disease may run the risk of a serious or life threatening allergic reaction if they consume spelt products.


Update : 7

Subject: Williams Foods, Inc. Issues Allergy Alert on Undeclared Milk in Bass Pro Shops Uncle Buck's Light 'N Krispy Fish Batter Mixes (March 18)

Williams Foods, Inc. Issues Allergy Alert on Undeclared Milk in Bass Pro Shops Uncle Buck's Light 'N Krispy Fish Batter Mixes (March 18)
Wed, 19 Mar 2008 13:12:00 -0500

The product is sold in Bass Pro Shops Uncle Buck's labeled 22 ounce canisters and 8 ounce flexible pouches. This recall applies to the following lot numbers: 31207A11, 35107A11, 06308A11 (22 ounce canisters) and 3530716 (8 ounce pouches). Only the "Light 'n Krispy" version of the Bass Pro Shop's Uncle Buck's Fish Batter Mixes are affected by this recall.


Update : 8

Subject: FDA Approves New Medical Adhesive to Treat Burn Patients

FDA Approves New Medical Adhesive to Treat Burn Patients
Wed, 19 Mar 2008 16:01:00 -0500

The U.S. Food and Drug Administration today approved a new medical adhesive (a fibrin sealant) called Artiss for use in attaching skin grafts onto burn patients.



This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420

Friday, March 14, 2008

U.S. Food & Drug Administration (FDA) Daily Digest Bulletin : CDER New 3/11 & 12/2008

FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

CDERnew Logo

March 12, 2008

March 11, 2008


Update : 2

Subject: Enforcement Report for March 12, 2008

Enforcement Report for March 12, 2008
Tue, 13 Mar 2007 07:08:00 -0500

Weekly report by the Food and Drug Administration, Department of Health and Human Services. It contains information on actions taken in connection with agency Regulatory activities.


Update : 3

Subject: Oncology Drugs Update: New Approval for Bevacizumab (Avastin)

FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

On February 22, 2008, the U.S. Food and Drug Administration granted accelerated approval for bevacizumab (Avastin, Genentech, Inc.) to be used in combination with paclitaxel for the treatment of patients who have not received chemotherapy for metastatic HER2 negative breast cancer. More information at http://www.fda.gov/cder/Offices/OODP/whatsnew/bevacizumab200802.htm


Update : 4

Subject: Important Information for the Safe Use of Tussionex Pennkinetic Extended-Release Suspension. Overview Version.

FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

Important Information for the Safe Use of Tussionex Pennkinetic Extended-Release Suspension. Overview Version.
Thu, 13 Mar 2008 16:00:00 -0500

Hydrocodone, the narcotic ingredient in this medicine that controls cough, can cause life-threatening breathing problems and death when given above or more frequently than the recommended dose. Tussionex should not be used in children less than 6 years old. Overview Version.


Update : 5

Subject: Important Information for the Safe Use of Tussionex Pennkinetic Extended-Release Suspension. Full Version.

FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

Important Information for the Safe Use of Tussionex Pennkinetic Extended-Release Suspension. Full Version.
Thu, 13 Mar 2008 16:00:00 -0500

Hydrocodone, the narcotic ingredient in this medicine that controls cough, can cause life-threatening breathing problems and death when given above or more frequently than the recommended dose. Tussionex should not be used in children less than 6 years old. Full Version.



This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420